173 related articles for article (PubMed ID: 7566970)
1. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.
Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR
Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
3. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
4. Sos1 rapidly associates with Grb2 and is hypophosphorylated when complexed with the EGF receptor after EGF stimulation.
Hu Y; Bowtell DD
Oncogene; 1996 May; 12(9):1865-72. PubMed ID: 8649846
[TBL] [Abstract][Full Text] [Related]
5. High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1.
Liao TJ; Jang H; Nussinov R; Fushman D
J Am Chem Soc; 2020 Feb; 142(7):3401-3411. PubMed ID: 31970984
[TBL] [Abstract][Full Text] [Related]
6. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
9. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
Charest A; Wagner J; Kwan M; Tremblay ML
Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
[TBL] [Abstract][Full Text] [Related]
10. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
11. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.
Li N; Batzer A; Daly R; Yajnik V; Skolnik E; Chardin P; Bar-Sagi D; Margolis B; Schlessinger J
Nature; 1993 May; 363(6424):85-8. PubMed ID: 8479541
[TBL] [Abstract][Full Text] [Related]
12. SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations.
Liao TJ; Jang H; Fushman D; Nussinov R
J Chem Phys; 2020 Jul; 153(4):045106. PubMed ID: 32752665
[TBL] [Abstract][Full Text] [Related]
13. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
15. p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus.
Byrne JL; Paterson HF; Marshall CJ
Oncogene; 1996 Nov; 13(10):2055-65. PubMed ID: 8950972
[TBL] [Abstract][Full Text] [Related]
16. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
17. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2.
VanderNoot VA; Fitzpatrick FA
Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.
Yuzawa S; Yokochi M; Hatanaka H; Ogura K; Kataoka M; Miura K; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 2001 Feb; 306(3):527-37. PubMed ID: 11178911
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K; Di Stasio E; Macchia G; Rosa G; Brancaccio A; Petrucci TC
Biochem Biophys Res Commun; 2000 Jul; 274(1):93-8. PubMed ID: 10903901
[TBL] [Abstract][Full Text] [Related]
20. The proline-rich region of Vav binds to Grb2 and Grb3-3.
Ramos-Morales F; Romero F; Schweighoffer F; Bismuth G; Camonis J; Tortolero M; Fischer S
Oncogene; 1995 Oct; 11(8):1665-9. PubMed ID: 7478592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
